Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.445
Abstract: This study aimed to investigate the bioequivalence of 2 formulations of gliclazide modified‐release tablets 60 mg in 48 healthy Caucasian volunteers under fasting conditions. A test product, Gliclazide MR (Ranbaxy Laboratories Limited, now Sun Pharmaceutical… read more here.
Keywords: healthy caucasian; bioequivalence; crossover; fasting conditions ... See more keywords
Computerised tomography skeletal muscle and adipose surface area values in a healthy Caucasian population
Sign Up to like & getrecommendations! Published in 2020 at "European Journal of Clinical Nutrition"
DOI: 10.1038/s41430-020-0628-1
Abstract: Background The analysis of computerised tomography (CT) images to provide body composition data has grown exponentially. Despite this, there remains limited published data defining the normal range of skeletal muscle area and adipose tissue area… read more here.
Keywords: healthy caucasian; skeletal muscle; muscle; caucasian population ... See more keywords
RELATIVE BIOAVAILABILITY OF TWO FORMULATIONS CONTAINING DAPAGLIFLOZIN 10 MG UNDER FED CONDITION IN A RANDOMIZED CROSSOVER STUDY IN HEALTHY CAUCASIAN SUBJECTS
Sign Up to like & getrecommendations! Published in 2020 at "Farmacia"
DOI: 10.31925/farmacia.2020.1.11
Abstract: The study aimed to evaluate the bioequivalence of a 10 mg dapagliflozin immediate release tablet, developed by Sun Pharmaceutical Industries, India, with the reference product Farxiga (AstraZeneca Pharmaceuticals LP, USA). The bioequivalence was assessed on… read more here.
Keywords: healthy caucasian; fed condition; study; crossover study ... See more keywords